Last reviewed · How we verify

NCT06292078: ISLA

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

Recruiting now NA Last updated 20 July 2025
What this trial tests

NA trial testing Instructional Skill-Building Learning Approach (ISLA) in Middle Schools in 5,076 participants. Currently enrolling.

Timeline
15 April 2024
Primary endpoint
1 October 2027
1 October 2027

Quick facts

Lead sponsorUniversity of Oregon
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment5,076
Start date15 April 2024
Primary completion1 October 2027
Estimated completion1 October 2027
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oregon

Who can join

Adults 8 to 15, any sex, with Middle Schools or School Exclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will test the effectiveness of the Inclusive Skill-building Learning Approach (ISLA) in reducing the use of exclusionary discipline, improving teacher practice and student outcomes, and decreasing substance misuse using a randomized controlled trial in 60 middle schools across six states.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Middle Schools

Currently open trials in the same condition.

Other University of Oregon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06292078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing